The majority are in the very early preclinical stage of development, but applications for regulatory approval have been submitted for 11 gene therapies worldwide, and 35 are in phase 3 trials, ...

International collaborations, refined gene-editing protocols, and targeted immunologic maneuvers keep the cancer gene therapy ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell and gene therapies. Their core ExPERT ATx, sTX, GTx, and VLx tools use ...

Gene regulation refers to the mechanisms that act to induce or repress the expression of a gene. These include structural and chemical changes to the genetic material, binding of proteins to ...

Gene expression is the generation of a functional gene product from the information encoded by a gene, through the processes of transcription and translation. Gene products are often proteins ...

The TP53 gene is a gene that is mutated in many cancers ... preventing other plumbers from getting near, speeding up the flow of water, and adding new leaky pipes around your home, including some that ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

Flow coin 1-day price analysis: FLOW is trading below the 78.6% Fibonacci retracement The FLOW 1-day price chart shows a bearish direction for the coin, with the price trading below the 78.6% ...

What place do stories of romance and marriage have in the pages of a newspaper? Join this conversation with the Vows writer Rosalie R. Radomsky by Feb. 14 to find out. By The Learning Network A ...